Skip to content
Moderna, Inc.

Moderna, Inc. technical analysis

MRNAHealthcare Updated daily

Technical analysis of Moderna, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Moderna, Inc.

Moderna, Inc. is a biotechnology company founded in 2010 and headquartered in Cambridge, Massachusetts, that develops medicines based on messenger RNA. The company produces vaccines for respiratory, viral, and bacterial diseases, as well as oncology therapeutics and products for rare diseases, operating in the United States, Europe, and internationally. Moderna collaborates with various healthcare and research organizations, including government agencies and foundations.

Description generated automatically from public sources; it may be inaccurate or out of date.

Moderna, Inc.: latest session data

Closing values for September 2, 2026, computed on the last 12 months of prices.

Close148.10 $
Change−4.00%
RSI (14)64.6
MACD23.211
ADX49.8
Volatility (ATR)9.53%
Volume vs 20-avg17%
12-month high176.66 $
12-month low43.68 $

Moving averages

21 sessions

106.26 $

+39.38%

50 sessions

81.96 $

+80.70%

200 sessions

53.59 $

+176.37%

Session levels

s2

132.41

Support

s1

143.34

Support

pivot

149.02

Pivot

r1

159.95

Resistance

r2

165.63

Resistance

How to read it

In the September 2, 2026 session Moderna, Inc. closed lower at 148.10 $, −4.00% versus the previous session.

The price sits above every moving average observed: +39.38% against the 21-session average, +80.70% against the 50 and +176.37% against the 200.

The 14-period RSI reads 64.6, in neutral territory.

MACD stands at 23.211 against a signal line at 20.314: the histogram is positive (+2.898).

ADX reads 49.8, indicating a marked directionality.

Levels computed on the latest session place supports at 143.34 and 132.41 $ and resistances at 159.95 and 165.63 $, around a pivot of 149.02.

The average daily range (ATR) is 14.117 $, or 9.53% of price.

Turnover was 5.5M shares, 17% of the 20-session average.

Over the last twelve months the price ranged between 43.68 and 176.66 $, and today stands −16.17% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Moderna, Inc.

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the MRNA analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Moderna, Inc.

How is Moderna, Inc. analysed technically?

Technical analysis of Moderna, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Moderna, Inc.?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Moderna, Inc.?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Moderna, Inc. it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.